Codes / ICD10CM / B87.9

B87.9 Myiasis, unspecified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Myiasis, unspecified

Summary

Myiasis, unspecified, refers to a parasitic infestation of live fly larvae (maggots) in human tissue where the specific body site or type of myiasis is not documented. The condition occurs when flies deposit eggs or larvae on a host, which then develop and feed on the host's tissue. It may range from superficial to invasive, depending on the fly species and host factors.

Causes

Myiasis, unspecified, is caused by the larvae of certain fly species, including blowflies, botflies, and screwworms. Flies may deposit eggs or larvae directly on the skin, in wounds, or on mucous membranes. The larvae then hatch and feed on the host's tissue, leading to infestation. Transmission typically occurs through contact with contaminated environments, animals, or flies.

Risk Factors

  • Poor hygiene or inadequate wound care.
  • Living in or traveling to regions with high fly populations.
  • Open wounds, ulcers, or skin lesions.
  • Prolonged exposure to decaying organic matter.
  • Immunocompromised states or underlying skin conditions.

Symptoms

  • Crawling or moving sensations in the affected area.
  • Visible larvae or maggots in wounds or skin.
  • Localized pain, itching, or irritation.
  • Swelling, redness, or discharge from the infested site.
  • Systemic symptoms (e.g., fever) in severe or invasive cases.

Diagnosis

Diagnosis is primarily clinical, based on the presence of larvae in the tissue or wounds. Healthcare providers may examine the affected area for visible maggots or larvae, assess symptoms, and consider the patient's history of exposure to flies or contaminated environments. Laboratory tests are rarely needed but may be used to rule out other conditions.

Treatment Options

Treatment typically involves mechanical removal of larvae, wound cleaning, and administration of topical or systemic antibiotics to prevent secondary infection. In some cases, larvae may be left in place to debride necrotic tissue (maggot therapy). Pain management and tetanus prophylaxis may also be necessary.

Prognosis and Follow-Up

Prognosis is generally good with prompt treatment, though outcomes depend on the severity of infestation and host factors. Follow-up care may include monitoring for infection, wound healing, and addressing underlying risk factors. Severe cases may require additional interventions.

Complications

  • Secondary bacterial infections.
  • Tissue damage or necrosis.
  • Systemic reactions (e.g., fever, allergic responses).
  • Delayed healing of wounds.

Lifestyle & Prevention

  • Maintain good hygiene and proper wound care.
  • Use insect repellents and protective clothing in high-risk areas.
  • Avoid contact with decaying organic matter or infested animals.
  • Seek prompt medical attention for open wounds or skin lesions.

When to Seek Professional Help

Seek medical care if you experience crawling sensations, visible larvae, or signs of infection (e.g., swelling, redness, discharge) in a wound or skin area, especially after exposure to flies or contaminated environments.

Tips for Medical Coders

Use B87.9 for cases of myiasis where the specific body site or type is not documented. Ensure documentation supports the unspecified nature of the infestation. If the site or type is known, assign the appropriate more specific code (e.g., cutaneous, wound, or visceral myiasis).

Book a walkthrough

B87.9 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.